Structure, Activity and Function of the NSD3 Proteinlysine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Plant SET Domain-Containing Proteins: Structure, Function and Regulation
Biochimica et Biophysica Acta 1769 (2007) 316–329 www.elsevier.com/locate/bbaexp Review Plant SET domain-containing proteins: Structure, function and regulation Danny W-K Ng, Tao Wang, Mahesh B. Chandrasekharan 1, Rodolfo Aramayo, ⁎ Sunee Kertbundit 2, Timothy C. Hall Institute of Developmental and Molecular Biology and Department of Biology, Texas A&M University, College Station, TX 77843-3155, USA Received 27 October 2006; received in revised form 3 April 2007; accepted 4 April 2007 Available online 12 April 2007 Abstract Modification of the histone proteins that form the core around which chromosomal DNA is looped has profound epigenetic effects on the accessibility of the associated DNA for transcription, replication and repair. The SET domain is now recognized as generally having methyltransferase activity targeted to specific lysine residues of histone H3 or H4. There is considerable sequence conservation within the SET domain and within its flanking regions. Previous reviews have shown that SET proteins from Arabidopsis and maize fall into five classes according to their sequence and domain architectures. These classes generally reflect specificity for a particular substrate. SET proteins from rice were found to fall into similar groupings, strengthening the merit of the approach taken. Two additional classes, VI and VII, were established that include proteins with truncated/ interrupted SET domains. Diverse mechanisms are involved in shaping the function and regulation of SET proteins. These include protein–protein interactions through both intra- and inter-molecular associations that are important in plant developmental processes, such as flowering time control and embryogenesis. Alternative splicing that can result in the generation of two to several different transcript isoforms is now known to be widespread. -
FGFR1 Fusion and Amplification in a Solid Variant of Alveolar Rhabdomyosarcoma
Modern Pathology (2011) 24, 1327–1335 & 2011 USCAP, Inc. All rights reserved 0893-3952/11 $32.00 1327 FOXO1–FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma Jinglan Liu1,2, Miguel A Guzman1,2, Donna Pezanowski1, Dilipkumar Patel1, John Hauptman1, Matthew Keisling3, Steve J Hou2,3, Peter R Papenhausen4, Judy M Pascasio1,2, Hope H Punnett1,5, Gregory E Halligan2,6 and Jean-Pierre de Chadare´vian1,2 1Department of Pathology and Laboratory Medicine, St Christopher’s Hospital for Children, Philadelphia, PA, USA; 2Drexel University College of Medicine, Philadelphia, PA, USA; 3Department of Pathology and Laboratory Medicine, Hahnneman University Hospital, Philadelphia, PA, USA; 4Laboratory Corporation of America, The Research Triangle Park, NC, USA; 5Department of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA, USA and 6Department of Pediatrics, Section of Oncology, St Christopher’s Hospital for Children, Philadelphia, PA, USA Rhabdomyosarcoma is the most common pediatric soft tissue malignancy. Two major subtypes, alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma, constitute 20 and 60% of all cases, respectively. Approximately 80% of alveolar rhabdomyosarcoma carry two signature chromosomal translocations, t(2;13)(q35;q14) resulting in PAX3–FOXO1 fusion, and t(1;13)(p36;q14) resulting in PAX7–FOXO1 fusion. Whether the remaining cases are truly negative for gene fusion has been questioned. We are reporting the case of a 9-month-old girl with a metastatic neck mass diagnosed histologically as solid variant alveolar rhabdomyosarcoma. Chromosome analysis showed a t(8;13;9)(p11.2;q14;9q32) three-way translocation as the sole clonal aberration. Fluorescent in situ hybridization (FISH) demonstrated a rearrangement at the FOXO1 locus and an amplification of its centromeric region. -
Automethylation of PRC2 Promotes H3K27 Methylation and Is Impaired in H3K27M Pediatric Glioma
Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma Chul-Hwan Lee,1,2,7 Jia-Ray Yu,1,2,7 Jeffrey Granat,1,2,7 Ricardo Saldaña-Meyer,1,2 Joshua Andrade,3 Gary LeRoy,1,2 Ying Jin,4 Peder Lund,5 James M. Stafford,1,2,6 Benjamin A. Garcia,5 Beatrix Ueberheide,3 and Danny Reinberg1,2 1Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA; 2Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA; 3Proteomics Laboratory, New York University School of Medicine, New York, New York 10016, USA; 4Shared Bioinformatics Core, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 5Department of Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA The histone methyltransferase activity of PRC2 is central to the formation of H3K27me3-decorated facultative heterochromatin and gene silencing. In addition, PRC2 has been shown to automethylate its core subunits, EZH1/ EZH2 and SUZ12. Here, we identify the lysine residues at which EZH1/EZH2 are automethylated with EZH2-K510 and EZH2-K514 being the major such sites in vivo. Automethylated EZH2/PRC2 exhibits a higher level of histone methyltransferase activity and is required for attaining proper cellular levels of H3K27me3. While occurring inde- pendently of PRC2 recruitment to chromatin, automethylation promotes PRC2 accessibility to the histone H3 tail. Intriguingly, EZH2 automethylation is significantly reduced in diffuse intrinsic pontine glioma (DIPG) cells that carry a lysine-to-methionine substitution in histone H3 (H3K27M), but not in cells that carry either EZH2 or EED mutants that abrogate PRC2 allosteric activation, indicating that H3K27M impairs the intrinsic activity of PRC2. -
Engaging Chromatin: PRC2 Structure Meets Function
www.nature.com/bjc REVIEW ARTICLE Engaging chromatin: PRC2 structure meets function Paul Chammas1, Ivano Mocavini1 and Luciano Di Croce1,2,3 Polycomb repressive complex 2 (PRC2) is a key epigenetic multiprotein complex involved in the regulation of gene expression in metazoans. PRC2 is formed by a tetrameric core that endows the complex with histone methyltransferase activity, allowing it to mono-, di- and tri-methylate histone H3 on lysine 27 (H3K27me1/2/3); H3K27me3 is a hallmark of facultative heterochromatin. The core complex of PRC2 is bound by several associated factors that are responsible for modulating its targeting specificity and enzymatic activity. Depletion and/or mutation of the subunits of this complex can result in severe developmental defects, or even lethality. Furthermore, mutations of these proteins in somatic cells can be drivers of tumorigenesis, by altering the transcriptional regulation of key tumour suppressors or oncogenes. In this review, we present the latest results from structural studies that have characterised PRC2 composition and function. We compare this information with data and literature for both gain-of function and loss-of-function missense mutations in cancers to provide an overview of the impact of these mutations on PRC2 activity. British Journal of Cancer (2020) 122:315–328; https://doi.org/10.1038/s41416-019-0615-2 BACKGROUND and embryonic ectoderm development (EED) (Table 1). These Transcriptional diversity is one of the hallmarks of cellular three proteins form the minimal core that confers histone identity. It is largely regulated at the level of chromatin, where methyltransferase (HMT) activity. A fourth factor, retinoblastoma- different protein complexes act as initiators, enhancers and/or binding protein (RBBP)4/7 (also known as RBAP48/46), has a repressors of transcription. -
Text-Based Analysis of Genes, Proteins, Aging, and Cancer
Mechanisms of Ageing and Development 126 (2005) 193–208 www.elsevier.com/locate/mechagedev Text-based analysis of genes, proteins, aging, and cancer Jeremy R. Semeiks, L.R. Grate, I.S. Mianà Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA Available online 26 October 2004 Abstract The diverse nature of cancer- and aging-related genes presents a challenge for large-scale studies based on molecular sequence and profiling data. An underexplored source of data for modeling and analysis is the textual descriptions and annotations present in curated gene- centered biomedical corpora. Here, 450 genes designated by surveys of the scientific literature as being associated with cancer and aging were analyzed using two complementary approaches. The first, ensemble attribute profile clustering, is a recently formulated, text-based, semi- automated data interpretation strategy that exploits ideas from statistical information retrieval to discover and characterize groups of genes with common structural and functional properties. Groups of genes with shared and unique Gene Ontology terms and protein domains were defined and examined. Human homologs of a group of known Drosphila aging-related genes are candidates for genes that may influence lifespan (hep/MAPK2K7, bsk/MAPK8, puc/LOC285193). These JNK pathway-associated proteins may specify a molecular hub that coordinates and integrates multiple intra- and extracellular processes via space- and time-dependent interactions with proteins in other pathways. The second approach, a qualitative examination of the chromosomal locations of 311 human cancer- and aging-related genes, provides anecdotal evidence for a ‘‘phenotype position effect’’: genes that are proximal in the linear genome often encode proteins involved in the same phenomenon. -
Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive Oncogenic Megadomain Formation in NUT Midline Carcinoma
Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma Artyom A. Alekseyenkoa,b,1, Erica M. Walshc,1, Barry M. Zeea,b, Tibor Pakozdid, Peter Hsic, Madeleine E. Lemieuxe, Paola Dal Cinc, Tan A. Incef,g,h,i, Peter V. Kharchenkod,j, Mitzi I. Kurodaa,b,2, and Christopher A. Frenchc,2 aDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; cDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; dDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115; eBioinfo, Plantagenet, ON, Canada K0B 1L0; fDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136; gBraman Family Breast Cancer Institute, University of Miami Miller School of Medicine, Miami, FL 33136; hInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; iSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; and jHarvard Stem Cell Institute, Cambridge, MA 02138 Contributed by Mitzi I. Kuroda, April 6, 2017 (sent for review February 7, 2017; reviewed by Sharon Y. R. Dent and Jerry L. Workman) To investigate the mechanism that drives dramatic mistargeting of and, in the case of MYC, leads to differentiation in culture (2, 3). active chromatin in NUT midline carcinoma (NMC), we have Similarly, small-molecule BET inhibitors such as JQ1, which identified protein interactions unique to the BRD4–NUT fusion disengage BRD4–NUT from chromatin, diminish megadomain- oncoprotein compared with wild-type BRD4. -
Structural Chemistry of Human SET Domain Protein Methyltransferases Matthieu Schapira*,1,2
Current Chemical Genomics, 2011, 5, (Suppl 1-M5) 85-94 85 Open Access Structural Chemistry of Human SET Domain Protein Methyltransferases Matthieu Schapira*,1,2 1Structural Genomics Consortium, University of Toronto, MaRS Centre, Toronto, Ontario, M5G 1L7, Canada 2 Department of Pharmacology and Toxicology, University of Toronto, Medical Sciences Building, Toronto, Ontario, M5S 1A8, Canada Abstract: There are about fifty SET domain protein methyltransferases (PMTs) in the human genome, that transfer a methyl group from S-adenosyl-L-methionine (SAM) to substrate lysines on histone tails or other peptides. A number of structures in complex with cofactor, substrate, or inhibitors revealed the mechanisms of substrate recognition, methylation state specificity, and chemical inhibition. Based on these structures, we review the structural chemistry of SET domain PMTs, and propose general concepts towards the development of selective inhibitors. Keywords: Methyltransferase, SET domain, structure, PMT, histone, epigenetics. INTRODUCTION activity, but sometimes recognize the methylation substrate or reaction product. For instance, it was shown that an An- Epigenetics mechanisms rely extensively on histone- kyrin repeat distinct from the catalytic domain of GLP could mediated signaling, in which chemical modifications can recognize mono- or di-methylated lysine 9 of histone 3, the make or break complex biological circuits [1, 2]. Among the very reaction product of GLP’s SET domain [16]. different histone marks, methylation of specific lysine and arginine side-chains can regulate chromatin compaction, As previously observed for histone deacetylases and his- repress or activate transcription, and control cellular differ- tone acetyltransferases, it is becoming clear that histones are entiation [3, 4]. The transfer of a methyl group from the co- not the only subtrates of some PMTs. -
Sleeping Beauty Mutagenesis Reveals Cooperating Mutations and Pathways in Pancreatic Adenocarcinoma
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma Karen M. Manna,1, Jerrold M. Warda, Christopher Chin Kuan Yewa, Anne Kovochichb, David W. Dawsonb, Michael A. Blackc, Benjamin T. Brettd, Todd E. Sheetzd,e,f, Adam J. Dupuyg, Australian Pancreatic Cancer Genome Initiativeh,2, David K. Changi,j,k, Andrew V. Biankini,j,k, Nicola Waddelll, Karin S. Kassahnl, Sean M. Grimmondl, Alistair G. Rustm, David J. Adamsm, Nancy A. Jenkinsa,1, and Neal G. Copelanda,1,3 aDivision of Genetics and Genomics, Institute of Molecular and Cell Biology, Singapore 138673; bDepartment of Pathology and Laboratory Medicine and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, CA 90095; cDepartment of Biochemistry, University of Otago, Dunedin, 9016, New Zealand; dCenter for Bioinformatics and Computational Biology, University of Iowa, Iowa City, IA 52242; eDepartment of Biomedical Engineering, University of Iowa, Iowa City, IA 52242; fDepartment of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; gDepartment of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; hAustralian Pancreatic Cancer Genome Initiative; iCancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia; jDepartment of Surgery, Bankstown Hospital, Bankstown, Sydney, New South Wales 2200, Australia; kSouth Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales 2170, Australia; lQueensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia; and mExperimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2009. -
WAPL Maintains Dynamic Cohesin to Preserve Lineage Specific Distal Gene Regulation
bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. WAPL maintains dynamic cohesin to preserve lineage specific distal gene regulation Ning Qing Liu1, Michela Maresca1, Teun van den Brand1, Luca Braccioli1, Marijne M.G.A. Schijns1, Hans Teunissen1, Benoit G. Bruneau2,3,4, Elphѐge P. Nora2,3, Elzo de Wit1,* Affiliations 1 Division Gene Regulation, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands; 2 Gladstone Institutes, San Francisco, USA; 3 Cardiovascular Research Institute, University of California, San Francisco; 4 Department of Pediatrics, University of California, San Francisco. *corresponding author: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. HIGHLIGHTS 1. The cohesin release factor WAPL is crucial for maintaining a pluripotency-specific phenotype. 2. Dynamic cohesin is enriched at lineage specific loci and overlaps with binding sites of pluripotency transcription factors. 3. Expression of lineage specific genes is maintained by dynamic cohesin binding through the formation of promoter-enhancer associated self-interaction domains. 4. CTCF-independent cohesin binding to chromatin is controlled by the pioneer factor OCT4. bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. -
Implications for the 8P12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, As an Oncogene
Medical University of South Carolina MEDICA MUSC Theses and Dissertations 2018 Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene Alexandria Colett Rutkovsky Medical University of South Carolina Follow this and additional works at: https://medica-musc.researchcommons.org/theses Recommended Citation Rutkovsky, Alexandria Colett, "Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene" (2018). MUSC Theses and Dissertations. 295. https://medica-musc.researchcommons.org/theses/295 This Dissertation is brought to you for free and open access by MEDICA. It has been accepted for inclusion in MUSC Theses and Dissertations by an authorized administrator of MEDICA. For more information, please contact [email protected]. Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene by Alexandria Colett Rutkovsky A dissertation submitted to the faculty of the Medical University of South Carolina in fulfillment of the requirements for the degree of Doctor of Philosophy in the College of Graduate Studies Biomedical Sciences Department of Pathology and Laboratory Medicine 2018 Approved by: Chairman, Advisory Committee Stephen P. Ethier Co-Chairman Robin C. Muise-Helmericks Amanda C. LaRue Victoria J. Findlay Elizabeth S. Yeh Copyright by Alexandria Colett Rutkovsky 2018 All Rights Reserved This work is dedicated to the fight against cancer. ACKNOWLEDGEMENTS I would like to acknowledge the Hollings Cancer Center and many departments at the Medical University of South Carolina for investing the resources and training required to complete the research presented. -
High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach
Journal of Personalized Medicine Article High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach Hyung-Suk Kim 1 , Kyueng-Whan Min 2,* , Dong-Hoon Kim 3,* , Byoung-Kwan Son 4 , Mi-Jung Kwon 5 and Sang-Mo Hong 6 1 Division of Breast Surgery, Department of Surgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea; [email protected] 2 Department of Pathology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea 3 Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunanro, Seoul 03181, Korea 4 Uijeongbu Eulji Medical Center, Department of Internal Medicine, Eulji University School of Medicine, Daejeon 34824, Korea; [email protected] 5 Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 24252, Korea; [email protected] 6 Division of Endocrinology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea; [email protected] * Correspondence: [email protected] (K.-W.M.); [email protected] (D.-H.K.); Tel.: +82-31-560-2346 (K.-W.M.); +82-2-2001-2392 (D.-H.K.); Fax: +82-2-31-560-2402 (K.-W.M.); +82-2-2001-2398 (D.-H.K.) Citation: Kim, H.-S.; Min, K.-W.; Kim, D.-H.; Son, B.-K.; Kwon, M.-J.; Abstract: Nuclear receptor-binding SET domain protein (NSD), a histone methyltransferase, is Hong, S.-M. High WHSC1L1 known to play an important role in cancer pathogenesis. The WHSC1L1 (Wolf-Hirschhorn syndrome Expression Reduces Survival Rates in candidate 1-like 1) gene, encoding NSD3, is highly expressed in breast cancer, but its role in the Operated Breast Cancer Patients with development of breast cancer is still unknown. -
In SUM-44 Breast Cancer Cells and Is Associated with Era Over-Expression in Breast Cancer
MOLECULAR ONCOLOGY 10 (2016) 850e865 available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc Amplification of WHSC1L1 regulates expression and estrogen- independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer Jonathan C. Irisha,b,1, Jamie N. Millsa,1, Brittany Turner-Iveya, Robert C. Wilsona, Stephen T. Guesta, Alexandria Rutkovskya, Alan Dombkowskib, Christiana S. Kapplera, Gary Hardimanc, Stephen P. Ethiera,* aDepartment of Pathology and Laboratory Medicine, Hollings Cancer Center, 86 Jonathan Lucas St, Charleston, SC 29425, USA bDepartment of Cancer Biology, Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI 48201, USA cDepartment of Medicine and Public Health, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA ARTICLE INFO ABSTRACT Article history: The 8p11-p12 amplicon occurs in approximately 15% of breast cancers in aggressive Received 30 November 2015 luminal B-type tumors. Previously, we identified WHSC1L1 as a driving oncogene from Received in revised form this region. Here, we demonstrate that over-expression of WHSC1L1 is linked to over- 17 February 2016 expression of ERa in SUM-44 breast cancer cells and in primary human breast cancers. Accepted 18 February 2016 Knock-down of WHSC1L1, particularly WHSC1L1-short, had a dramatic effect on ESR1 Available online 27 February 2016 mRNA and ERa protein levels. SUM-44 cells do not require exogenous estrogen for growth in vitro; however, they are dependent on ERa expression, as ESR1 knock-down or exposure Keywords: to the selective estrogen receptor degrader fulvestrant resulted in growth inhibition.